{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T12:14:57Z","timestamp":1648815297125},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T00:00:00Z","timestamp":1460764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Foundation of Science and technology, Portugal","award":["SFRH\/BPD\/2008\/44469"],"award-info":[{"award-number":["SFRH\/BPD\/2008\/44469"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00044-016-1578-y","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T03:15:45Z","timestamp":1460776545000},"page":"1340-1357","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Binding mode of conformations and structure-based pharmacophore development for farnesyltransferase inhibitors"],"prefix":"10.1007","volume":"25","author":[{"given":"N. S. Hari Narayana","family":"Moorthy","sequence":"first","affiliation":[]},{"given":"Sergio F.","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Maria J.","family":"Ramos","sequence":"additional","affiliation":[]},{"given":"Pedro A.","family":"Fernandes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"key":"1578_CR1","doi-asserted-by":"publisher","first-page":"e63030","DOI":"10.1371\/journal.pone.0063030","volume":"8","author":"M Arooj","year":"2013","unstructured":"Arooj M, Sakkiah S, Kim S, Arulalapperumal V, Lee KW (2013) A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors. PLoS One 8:e63030. doi: 10.1371\/journal.pone.0063030","journal-title":"PLoS One"},{"key":"1578_CR2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bmc.2012.10.034","volume":"21","author":"F Bellesia","year":"2013","unstructured":"Bellesia F, Choi SR, Felluga F, Fiscaletti G, Ghelfi F, Menziani MC, Parsons AF, Poulter CD, Roncaglia F, Sabbatini M, Spinelli D (2013) Novel route to chaetomellic acid A and analogues: serendipitous discovery of a more competent FTase inhibitor. Bioorg Med Chem 21:348\u2013358","journal-title":"Bioorg Med Chem"},{"key":"1578_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0166-6851(02)00099-3","volume":"122","author":"FS Buckner","year":"2002","unstructured":"Buckner FS, Eastman RT, Nepomuceno-Silva JL, Speelmon EC, Myler PJ, Van Voorhis WC, Yokoyama K (2002) Cloning, heterologous expression, and substrate specificities of protein farnesyltransferases from Trypanosoma cruzi and Leishmania major. Mol Biochem Parasitol 122:181\u2013188","journal-title":"Mol Biochem Parasitol"},{"key":"1578_CR4","first-page":"791","volume":"6","author":"FS Buckner","year":"2005","unstructured":"Buckner FS, Eastman RT, Yokoyama K, Gelb MH, Van Voorhis WC (2005) Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis. Curr Opin Invest Drugs 6:791\u2013797","journal-title":"Curr Opin Invest Drugs"},{"key":"1578_CR5","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0506001102","volume":"102","author":"BC Capell","year":"2005","unstructured":"Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD, Collins FC (2005) Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 102:12879\u201312884","journal-title":"Proc Natl Acad Sci USA"},{"key":"1578_CR6","volume-title":"AMBER 12","author":"DA Case","year":"2012","unstructured":"Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Hayik S, Roitberg A, Seabra G, Swails J, G\u00f6tz AW, Kolossv\u00e1ry I, Wong KF, Paesani F, Vanicek J, Wolf RM, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Salomon-Ferrer R, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA (2012) AMBER 12. University of California, San Francisco"},{"key":"1578_CR7","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1074\/jbc.271.10.5289","volume":"271","author":"PJ Casey","year":"1996","unstructured":"Casey PJ, Seabra MC (1996) Protein prenyltransferases. J Biol Chem 271:5289\u20135292","journal-title":"J Biol Chem"},{"key":"1578_CR8","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1021\/ci600246s","volume":"46","author":"J Chen","year":"2006","unstructured":"Chen J, Lai L (2006) Pocket v. 2: further developments on receptor-based pharmacophore modelling. J Chem Inf Model 46:2684\u20132691","journal-title":"J Chem Inf Model"},{"key":"1578_CR9","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1074\/jbc.M413556200","volume":"280","author":"RT Eastman","year":"2005","unstructured":"Eastman RT, White J, Hucke O, Bauer K, Yokoyama K, Nallan L, Chakrabarti D, Verlinde CL, Gelb MH, Rathod PK, Van Voorhis WC (2005) Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum. J Biol Chem 280:13554\u201313559","journal-title":"J Biol Chem"},{"key":"1578_CR10","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1021\/jm050456x","volume":"48","author":"MI Esteva","year":"2005","unstructured":"Esteva MI, Kettler K, Maidana C, Fichera L, Ruiz AM, Bontempi EJ, Andersson B, Dahse HM, Haebel P, Ortmann R, Klebe G, Schlitzer M (2005) Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi. J Med Chem 48:7186\u20137191","journal-title":"J Med Chem"},{"key":"1578_CR11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2174\/1568026023392940","volume":"2","author":"OF Guner","year":"2002","unstructured":"Guner OF (2002) History and evolution of the pharmacophore concept in computer-aided drug design. Curr Top Med Chem 2:1321\u20131332","journal-title":"Curr Top Med Chem"},{"key":"1578_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chembiol.2009.01.014","volume":"16","author":"MA Hast","year":"2009","unstructured":"Hast MA, Fletcher S, Cummings CG, Pusateri EE, Blaskovich MA, Rivas K, Gelb MH, Van Voorhis WC, Sebti SM, Hamilton AD, Beese LS (2009) Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase. Chem Biol 16:181\u2013192","journal-title":"Chem Biol"},{"key":"1578_CR13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65:712\u2013725","journal-title":"Proteins"},{"key":"1578_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD\u2014visual molecular dynamics. J Mol Graph\u00a014:33\u201338","journal-title":"J Mol Graph"},{"key":"1578_CR15","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1021\/ci4005207","volume":"53","author":"R Kurczab","year":"2013","unstructured":"Kurczab R, Bojarski AJ (2013) New strategy for receptor-based pharmacophore query construction: a case study for 5-HT7 receptor ligands. J Chem Inf Model 53:3233\u20133243","journal-title":"J Chem Inf Model"},{"key":"1578_CR16","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1073\/pnas.241407898","volume":"98","author":"SB Long","year":"2001","unstructured":"Long SB, Hancock PJ, Kral AM, Hellinga HW, Beese LS (2001) The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics. Proc Natl Acad Sci USA 98:12948\u201312953","journal-title":"Proc Natl Acad Sci USA"},{"key":"1578_CR17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nature00986","volume":"419","author":"SB Long","year":"2002","unstructured":"Long SB, Casey PJ, Beese LS (2002) Reaction path of protein farnesyltransferase at atomic resolution. Nature 419:645\u2013650","journal-title":"Nature"},{"key":"1578_CR18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10822-009-9268-1","volume":"23","author":"K Loving","year":"2009","unstructured":"Loving K, Salam NK, Sherman W (2009) Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation. J Comput Aided Mol Des 23:541\u2013554","journal-title":"J Comput Aided Mol Des"},{"key":"1578_CR19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/ci300083r","volume":"52","author":"J Meslamani","year":"2012","unstructured":"Meslamani J, Li J, Sutter J, Stevens A, Bertrand HO, Rognan D (2012) Protein\u2013ligand-based pharmacophores: generation and utility assessment in computational ligand profiling. J Chem Inf Model 52:943\u2013955","journal-title":"J Chem Inf Model"},{"key":"1578_CR20","unstructured":"MOE (Molecular Operating Environment) (2013) Chemical Computing Group Inc. Montreal, H3A 2R7 Canada"},{"issue":"6","key":"1578_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/14756366.2011.552885","volume":"26","author":"NSHN Moorthy","year":"2011","unstructured":"Moorthy NSHN, Sousa SF, Fernandes PA, Ramos MJ (2011a) Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors. J Enz Inhibit Med Chem 26(6):777\u2013791","journal-title":"J Enz Inhibit Med Chem"},{"key":"1578_CR22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/1087057111414899","volume":"16","author":"NSHN Moorthy","year":"2011","unstructured":"Moorthy NSHN, Sousa SF, Ramos MJ, Fernandes PA (2011b) In silico based structural analysis of arylthiophene derivatives for FTase inhibitory activity, hERG and other toxic effects. J Biomol Screen 16:1037\u20131046","journal-title":"J Biomol Screen"},{"key":"1578_CR23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/157340612802084171","volume":"8","author":"NSHN Moorthy","year":"2012","unstructured":"Moorthy NSHN, Sousa SF, Fernandes PA, Ramos MJ (2012) In silico based structural analysis of some piperidine analogs as farnesyltransferase inhibitors. Med Chem 8:853\u2013864","journal-title":"Med Chem"},{"key":"1578_CR24","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.2174\/09298673113206660262","volume":"20","author":"NSHN Moorthy","year":"2013","unstructured":"Moorthy NSHN, Sousa SF, Ramos MJ, Fernandes PA (2013) Farnesyltransferease inhibitors: a comprehensive review based on quantitative structural analysis. Curr Med Chem 20:4888\u20134923","journal-title":"Curr Med Chem"},{"key":"1578_CR25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chemolab.2014.11.009","volume":"140","author":"NSHN Moorthy","year":"2015","unstructured":"Moorthy NSHN, Cerquira NMFS, Fernandes PA, Ramos MJ (2015) Ligand based analysis on HMG-CoA reductase inhibitors. Chemom Intell Lab Syst 140:102\u2013116","journal-title":"Chemom Intell Lab Syst"},{"key":"1578_CR26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/jm030236o","volume":"47","author":"J Ohkanda","year":"2004","unstructured":"Ohkanda J, Buckner FS, Lockman JW, Yokoyama K, Carrico D, Eastman R, Luca-Fradley K, Davies W, Croft SL, Van Voorhis WC, Gelb MH, Sebti SM, Hamilton AD (2004) Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. J Med Chem 47:432\u2013445","journal-title":"J Med Chem"},{"key":"1578_CR27","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.275.5307.1800","volume":"275","author":"HW Park","year":"1997","unstructured":"Park HW, Boduluri SR, Moomaw JF, Casey PJ, Beese LS (1997) Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution. Science 275:1800\u20131804","journal-title":"Science"},{"key":"1578_CR28","doi-asserted-by":"crossref","first-page":"51243","DOI":"10.1074\/jbc.M309226200","volume":"278","author":"JS Pickett","year":"2003","unstructured":"Pickett JS, Bowers KE, Fierke CA (2003a) Mutagenesis studies of protein farnesyltransferase implicate aspartate {beta}352 as a magnesium ligand. J Biol Chem 278:51243\u201351250","journal-title":"J Biol Chem"},{"key":"1578_CR29","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1021\/bi0346852","volume":"42","author":"JS Pickett","year":"2003","unstructured":"Pickett JS, Bowers KE, Hartman HL, Fu HW, Embry AC, Casey PJ, Fierke CA (2003b) Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation. Biochemistry 42:9741\u20139748","journal-title":"Biochemistry"},{"key":"1578_CR30","doi-asserted-by":"crossref","first-page":"9000","DOI":"10.1021\/bi049280b","volume":"43","author":"TS Reid","year":"2004","unstructured":"Reid TS, Long SB, Beese LS (2004a) Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-I by different binding modes. Biochemistry 43:9000\u20139008","journal-title":"Biochemistry"},{"key":"1578_CR31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jmb.2004.08.056","volume":"343","author":"TS Reid","year":"2004","unstructured":"Reid TS, Terry KL, Casey PJ, Beese LS (2004b) Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. J Mol Biol 343:417\u2013433","journal-title":"J Mol Biol"},{"key":"1578_CR32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/ci0503614","volume":"46","author":"M Rella","year":"2006","unstructured":"Rella M, Rushworth CA, Guy JL, Turner AJ, Langer T, Jackson RM (2006) Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. J Chem Inf Model 46:708\u2013716","journal-title":"J Chem Inf Model"},{"key":"1578_CR33","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/ci200088d","volume":"51","author":"MPA Sanders","year":"2011","unstructured":"Sanders MPA, Verhoeven S, de Graaf C, Roumen L, Vroling B, Nabuurs NB, de Vlieg J, Klomp JPG (2011) Snooker: a structure-based pharmacophore generation tool applied to class A GPCRs. J Chem Inf Model 51:2277\u20132292","journal-title":"J Chem Inf Model"},{"issue":"2","key":"1578_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.drudis.2014.10.002","volume":"20","author":"M Shen","year":"2015","unstructured":"Shen M, Pan P, Li Y, Li D, Yu H, Hou T (2015) Farnesyltransferase and geranylgeranyltransferase I: structures, mechanism, inhibitors and molecular modelling. Drug Discov Today 20(2):267\u2013276. doi: 10.1016\/j.drudis.2014.10.002","journal-title":"Drug Discov Today"},{"key":"1578_CR35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1529\/biophysj.104.048207","volume":"88","author":"SF Sousa","year":"2005","unstructured":"Sousa SF, Fernandes PA, Ramos MJ (2005) Farnesyltransferase\u2014new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism. Biophys J 88:483\u2013494","journal-title":"Biophys J"},{"key":"1578_CR36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00214-006-0170-9","volume":"117","author":"SF Sousa","year":"2007","unstructured":"Sousa SF, Fernandes PA, Ramos MJ (2007a) Effective tailor-made force field parameterization of the several Zn coordination environments in the puzzling FTase enzyme: opening the door to the full understanding of its elusive catalytic mechanism. Theor Chem Acc 117:171\u2013181","journal-title":"Theor Chem Acc"},{"key":"1578_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/prot.21219","volume":"66","author":"SF Sousa","year":"2007","unstructured":"Sousa SF, Fernandes PA, Ramos MJ (2007b) Theoretical studies on farnesyltransferase: the distances paradox explained. Proteins 66:205\u2013218","journal-title":"Proteins"},{"key":"1578_CR38","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jcc.20577","volume":"28","author":"SF Sousa","year":"2007","unstructured":"Sousa SF, Fernandes PA, Ramos MJ (2007c) Theoretical studies on farnesyltransferase: evidence for thioether product coordination to the active-site zinc sphere. J Comput Chem 28:1160\u20131168","journal-title":"J Comput Chem"},{"key":"1578_CR39","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1021\/jp711214j","volume":"112","author":"SF Sousa","year":"2008","unstructured":"Sousa SF, Fernandes PA, Ramos MJ (2008) Enzyme flexibility and the catalytic mechanism of farnesyltransferase: targeting the relation. J Phys Chem B 112:8681\u20138691","journal-title":"J Phys Chem B"},{"key":"1578_CR40","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.bmc.2009.03.055","volume":"17","author":"SF Sousa","year":"2009","unstructured":"Sousa SF, Fernandes PA, Ramos MJ (2009) Molecular dynamics simulations on the critical states of the farnesyltransferase enzyme. Bioorg Med Chem 17:3369\u20133378","journal-title":"Bioorg Med Chem"},{"key":"1578_CR41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00894-012-1590-1","volume":"19","author":"SF Sousa","year":"2013","unstructured":"Sousa SF, Coimbra JTS, Paramos D, Pinto R, Guimar\u00e3es RS, Teixeira V, Fernandes PA, Ramos MJ (2013) Molecular dynamics analysis of a series of 22 potential farnesyltransferase substrates containing a CaaX-motif. J Mol Model 19:673\u2013688","journal-title":"J Mol Model"},{"key":"1578_CR42","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1093\/emboj\/cdg571","volume":"22","author":"JS Taylor","year":"2003","unstructured":"Taylor JS, Reid TS, Terry KL, Casey PJ, Beese LS (2003) Structure of mammalian protein geranylgeranyltransferase type-I. EMBO J 22:5963\u20135974","journal-title":"EMBO J"},{"key":"1578_CR43","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1021\/ja035927o","volume":"125","author":"DA Tobin","year":"2003","unstructured":"Tobin DA, Pickett JS, Hartman HL, Fierke CA, Penner-Hahn JE (2003) Structural characterization of the zinc site in protein farnesyltransferase. J Am Chem Soc 125:9962\u20139969","journal-title":"J Am Chem Soc"},{"key":"1578_CR44","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.1021\/bi700516m","volume":"46","author":"JM Troutman","year":"2007","unstructured":"Troutman JM, Subramanian T, Andres DA, Spielmann HP (2007) Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues. Biochemistry 46:11310\u201311321","journal-title":"Biochemistry"},{"key":"1578_CR45","doi-asserted-by":"crossref","first-page":"38672","DOI":"10.1039\/C4RA05728G","volume":"4","author":"P Vasanthanathan","year":"2014","unstructured":"Vasanthanathan P, Moorthy NSHN, Kongsted J (2014) Dual mechanism of HIV-1 integrase and RNase H inhibition by diketo derivatives: a computational study. RSC Adv 4:38672\u201338681","journal-title":"RSC Adv"},{"key":"1578_CR46","doi-asserted-by":"crossref","first-page":"26497","DOI":"10.1074\/jbc.273.41.26497","volume":"273","author":"K Yokoyama","year":"1998","unstructured":"Yokoyama K, Trobridge P, Buckner FS, Van Voorhis WC, Stuart KD, Gelb MH (1998) Protein farnesyltransferase from Trypanosoma brucei. A heterodimer of 61- and 65-kDa subunits as a new target for antiparasite therapeutics. J Biol Chem 273:26497\u201326505","journal-title":"J Biol Chem"},{"key":"1578_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","volume":"65","author":"FL Zhang","year":"1996","unstructured":"Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241\u2013269","journal-title":"Annu Rev Biochem"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-016-1578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00044-016-1578-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-016-1578-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T11:34:41Z","timestamp":1558524881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00044-016-1578-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1578"],"URL":"https:\/\/doi.org\/10.1007\/s00044-016-1578-y","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}